Delivery Order 36C25022D0022-36C25024N0252
- Not listed
- The Department of Veterans Affairs Veterans Health Administration (VA VHA) awarded a Delivery Order to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, to provide EMERGENCY BIOFIRE FILM ARRAY diagnostic products. The $210,076.64 firm-fixed-price contract supports the Coronavirus COVID-19 National Interest Action and was issued against Biofire's existing GSA Federal Supply Schedule contract for in-vitro diagnostics. Biofire Diagnostics is a leader in syndromic infectious...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, a $126,652.50 firm-fixed-price purchase order for BioFire RP2.1 panel reagents. The contract has a completion date of February 15, 2022 and was awarded on December 3, 2020. Biofire Diagnostics is a leader in syndromic infectious disease testing and has received numerous federal contracts from agencies such as the VA, Defense Health Agency,...
- This contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company that specializes in syndromic infectious disease testing. The one-year, $808,537.12 delivery order contract is for Firm Fixed Price infectious disease testing products and services, including molecular diagnostic testing, COVID-19 testing reagents and equipment, maintenance services, and supply of reagents and test...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a delivery order to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, to provide BIOFIRE REAGENTS FOR TESTING COVID-19. The $438,741.54 firm-fixed-price order was placed against Biofire's existing General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. No set-aside was used. Biofire is a leader in syndromic infectious disease...
- This federal contract award was issued by the Veterans Integrated Service Network (VISN) 9, a component of the U.S. Department of Veterans Affairs (VA), to Biofire Diagnostics LLC, a foreign-owned biotechnology company specializing in advanced molecular diagnostic testing solutions. The $6,547,766.36 Firm Fixed Price Delivery Order contract is for BIOFIRE TESTING PANELS and a DECREASE TO TVHS PO, with a performance period through September 30, 2024. The contract was awarded on October 1, 2019...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network (VISN) 10 awarded a $132,640.50 firm-fixed-price purchase order to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, for the FILMARRAY SYSTEM. This award is part of the VA's response to the Coronavirus COVID-19 national emergency. Biofire Diagnostics is a leader in syndromic infectious disease testing and has received multiple federal contracts as a prime contractor...
- This federal contract award to Biofire Diagnostics LLC, a foreign-owned for-profit organization, is for molecular pathogen detection services. The $654,849 Firm Fixed Price contract was issued by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 8 against Biofire's existing General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. The contract has no set-aside designation. Biofire Diagnostics has...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a $241,326.46 firm-fixed-price delivery order to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, for the provision of BIOFIRE REAGENTS & VERIFICATION KITS. The order was placed against Biofire's existing General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. This delivery order does not have a set-aside designation. Biofire...
- This is a $34,704 firm-fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Biofire Diagnostics LLC, a foreign-owned for-profit biotechnology company specializing in advanced molecular diagnostic testing solutions. The contract is funded through the VA's Veterans Integrated Service Network 23 (VISN 23) and will support the delivery of BIOFIRE products and services through September 30, 2023. Biofire Diagnostics is an experienced federal contractor, holding...
- This federal contract award to Biofire Diagnostics LLC, a foreign-owned for-profit biotechnology company, was issued by the Department of Veterans Affairs' Veterans Integrated Service Network 10. The $87,232.50 firm-fixed-price delivery order contract is for the provision of specialized diagnostic testing panels, reagents, and associated services. The contract has an ultimate completion date of January 16, 2024 and was awarded on November 30, 2021. Biofire Diagnostics is an experienced federal...
- 36C25022D0022Indefinite Delivery Contract
- 36C25022D0022-36C25024N0252Delivery Order
The U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 10 awarded a Firm Fixed Price Delivery Order contract to Biofire Diagnostics LLC, a foreign-owned for-profit organization, to provide Biofire reagents through December 31, 2026. The initial delivery order value is $550,736.25. Biofire Diagnostics LLC is a leading provider of syndromic infectious disease testing products and services to federal agencies, including the VA, Defense Health Agency, Indian Health Service, and Department of State. The contract has no set-aside designation and is part of Biofire's existing General Services Administration Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. Biofire has also received previous federal contract and grant awards, including serving as a subcontractor for COVID-19 test reproducibility studies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $550.7k | 12/29/23 |